Towards better delivery of cannabidiol (CBD)

SA Millar, RF Maguire, AS Yates, SE O'Sullivan - Pharmaceuticals, 2020 - mdpi.com
Cannabidiol (CBD) has substantial therapeutic potential, but its development as an effective
drug by the pharmaceutical industry is hindered by intrinsic characteristics such as low …

Cannabinoid formulations and delivery systems: Current and future options to treat pain

B Stella, F Baratta, C Della Pepa, S Arpicco, D Gastaldi… - Drugs, 2021 - Springer
The field of Cannabis sativa L. research for medical purposes has been rapidly advancing in
recent decades and a growing body of evidence suggests that phytocannabinoids are …

A review of hemp as food and nutritional supplement

P Cerino, C Buonerba, G Cannazza… - Cannabis and …, 2021 - liebertpub.com
The term “hemp” refers to Cannabis sativa cultivars grown for industrial purposes that are
characterized by lower levels of tetrahydrocannabinol (THC), the active principle …

The effects of cannabidiol, a non-intoxicating compound of cannabis, on the cardiovascular system in health and disease

A Kicman, M Toczek - International journal of molecular sciences, 2020 - mdpi.com
Cannabidiol (CBD) is a non-intoxicating and generally well-tolerated constituent of cannabis
which exhibits potential beneficial properties in a wide range of diseases, including …

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

JC Arnold, D McCartney, A Suraev… - Clinical and …, 2023 - Wiley Online Library
Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is
increasing with claims of therapeutic effects across a diversity of health conditions. At …

Current challenges and opportunities for improved cannabidiol solubility

KR Hossain, A Alghalayini, SM Valenzuela - International Journal of …, 2023 - mdpi.com
Cannabidiol (CBD), derived from the cannabis plant, has gained significant attention due to
its potential therapeutic benefits. However, one of the challenges associated with CBD …

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties

EFSA Panel on Nutrition, Novel Foods and Food … - EFSA …, 2022 - Wiley Online Library
Abstract The European Commission has determined that cannabidiol (CBD) can be
considered as a novel food (NF), and currently, 19 applications are under assessment at …

The Skin and Natural Cannabinoids–Topical and Transdermal Applications

SI Filipiuc, AN Neagu, CM Uritu, BI Tamba, LE Filipiuc… - Pharmaceuticals, 2023 - mdpi.com
The chemical constituents of the Cannabis plant known as cannabinoids have been
extensively researched for their potential therapeutic benefits. The use of cannabinoids …

[PDF][PDF] The effects of cannabidiol oil on noninvasive measures of muscle damage in men

KC Cochrane-Snyman, C Cruz… - Medicine & Science in …, 2021 - researchgate.net
The Effects of Cannabidiol Oil on Noninvasive Measures of Muscle Damage in Men Page 1
Downloaded from https://journals.lww.com/acsm-msse by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78 …

[HTML][HTML] CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial

M Kumric, G Dujic, J Vrdoljak, K Svagusa… - Biomedicine & …, 2023 - Elsevier
Data concerning the effects of cannabidiol (CBD) on blood pressure (BP) is controversial.
HYPER-H21–4 was a randomized, placebo-controlled, crossover trial which sought to …